Nuclear chromatin-associated is enriched in PKCθ in circulating tumor cells in patients with triple-negative breast cancer (TNBC) brain metastases and immunotherapy-resistant metastatic melanoma and has been associated with poor survival in immunotherapy-resistant disease. Here, PRRT2 is linked to neoplasm.